Active, not recruitingNCT05911763

A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

Studying Hemophilia

Last synced from ClinicalTrials.gov May 10, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sanofi
Principal Investigator: Clinical Sciences & Operations
Sanofi
Intervention: Efanesoctocog Alfa BIVV001(drug)
Enrollment: 200 enrolled
Eligibility: All sexes
Timeline: 2023 – 2030

Study locations (28)

Banner MD Anderson Cancer Center- Site Number : 8400008, Gilbert, Arizona, United States
Loma Linda University- Site Number : 8400015, Loma Linda, California, United States
Orthopedic Institute for Children- Site Number : 8400004, Los Angeles, California, United States
The Center for Inherited Blood Disorders- Site Number : 8400001, Orange, California, United States
University of Colorado Hemophilia and Thrombosis Center- Site Number : 8400019, Aurora, Colorado, United States
William A. Shands Hospital at the University of Florida- Site Number : 8400032, Gainesville, Florida, United States
Johns Hopkins All Childrens Hospital - Outpatient Care Center - PIN- Site Number : 8400025, St. Petersburg, Florida, United States
Rush University Medical Center -1725 W Harrison St- Site Number : 8400014, Chicago, Illinois, United States
The Bleeding and Clotting Disorders Institute- Site Number : 8400005, Peoria, Illinois, United States
Indiana Hemophilia and Thrombosis Center- Site Number : 8400013, Indianapolis, Indiana, United States
University Of Iowa Hospitals And Clinics- Site Number : 8400026, Iowa City, Iowa, United States
~Massachusetts General Hospital- Site Number : 8400017, Boston, Massachusetts, United States
Dana Farber and Boston Children's Hospital- Site Number : 8400031, Boston, Massachusetts, United States
University of Michigan Hospital - 1500 E Medical Center Dr- Site Number : 8400023, Ann Arbor, Michigan, United States
M Health Fairview- Masonic Cancer Clinic - Clinics- Site Number : 8400010, Minneapolis, Minnesota, United States
+13 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05911763 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials